Table 2 Immunohistochemical analyses of relevant markers for Ovarian Cancer (2000–2015)
From: Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico
|  | Total n = 170 | Serous n = 110 |
|---|---|---|
P53 | ||
 Negative | 6 (3.53%) | 3 (2.73%) |
 Positive | 18 (10.59%) | 13 (11.82%) |
 Borderline | 1 (0.59%) | 0 |
 Missing | 145 | 94 |
Estrogen Receptor | ||
 Negative | 5 (2.94%) | 3 (2.73%) |
 Positive | 26 (15.29%) | 15 (13.64%) |
 Borderline | 0 | 0 |
 Missing | 139 | 92 |
Progesterone Receptor | ||
 Negative | 4 (2.35%) | 4 (3.64%) |
 Positive | 10 (5.88%) | 2 (1.82%) |
 Borderline | 0 | 0 |
 Missing | 156 | 104 |
CA125 | ||
 Negative | 1 (0.59%) | 0 |
 Positive | 41 (24.12%) | 31 (28.18%) |
 Borderline | 2 (1.18%) | 1 (0.91%) |
 Missing | 126 | 78 |
Cytokeratin 5/6 | ||
 Negative | 4 (2.35%) | 1 (0.91%) |
 Positive | 5 (2.94%) | 4 (3.64%) |
 Borderline | 0 | 0 |
 Missing | 161 | 105 |
Ki67 (Proliferative index) | ||
 Low | 0 | 0 |
 Moderate | 2 (1.18%) | 2 (1.82%) |
 High | 4 (2.35%) | 2 (1.82%) |
 Missing | 164 | 106 |